Cidara Therapeutics (CDTX) Current Leases: 2019-2025
Historic Current Leases for Cidara Therapeutics (CDTX) over the last 7 years, with Sep 2025 value amounting to $1.6 million.
- Cidara Therapeutics' Current Leases rose 18.00% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 18.00%. This contributed to the annual value of $1.4 million for FY2024, which is 27.36% up from last year.
- Per Cidara Therapeutics' latest filing, its Current Leases stood at $1.6 million for Q3 2025, which was up 4.21% from $1.5 million recorded in Q2 2025.
- Cidara Therapeutics' Current Leases' 5-year high stood at $1.6 million during Q3 2025, with a 5-year trough of $484,000 in Q2 2021.
- In the last 3 years, Cidara Therapeutics' Current Leases had a median value of $1.3 million in 2024 and averaged $1.2 million.
- As far as peak fluctuations go, Cidara Therapeutics' Current Leases tumbled by 44.87% in 2021, and later surged by 133.26% in 2022.
- Cidara Therapeutics' Current Leases (Quarterly) stood at $1.1 million in 2021, then climbed by 5.49% to $1.2 million in 2022, then declined by 10.65% to $1.1 million in 2023, then rose by 27.36% to $1.4 million in 2024, then climbed by 18.00% to $1.6 million in 2025.
- Its last three reported values are $1.6 million in Q3 2025, $1.5 million for Q2 2025, and $1.4 million during Q1 2025.